Literature DB >> 10205240

Salt-sensitive hypertension develops after short-term exposure to Angiotensin II.

D Lombardi1, K L Gordon, P Polinsky, S Suga, S M Schwartz, R J Johnson.   

Abstract

We hypothesized that short-term exposure to angiotensin II (Ang II) could result in structural and functional changes in the kidney that would favor sodium retention and the development of sustained hypertension. To test this hypothesis, rats were exposed to pressor doses (435 ng. kg-1. min-1) of Ang II for 2 weeks. The infusion of Ang II was associated with acute hypertension, renal dysfunction, proteinuria, and focal tubulointerstitial and vascular damage. At sites of the tubulointerstitial damage, there was a reduction in peritubular capillary endothelial cell staining. By use of immunostaining, we found focal loss of endothelial nitric oxide synthase (eNOS) in the peritubular capillaries at sites of injury and a generalized reduction in eNOS in collecting ducts, thin loops of Henle, and vascular bundles in the medulla. When the Ang II infusion ended, the rats became normotensive and renal function returned toward normal. However, exposure of the rats to high salt diet (4% NaCl) resulted in the redevelopment of hypertension after 3 to 4 weeks. Rats maintained on a high salt diet with no prior exposure to Ang II and rats placed on low salt diet (0.1% NaCl) after exposure to Ang II remained normotensive. Thus, we report a new model of salt-sensitive hypertension induced by transient exposure to pressor doses of Ang II. The mechanism may relate to microvascular injury with peritubular capillary loss coupled with functional changes, such as a loss in intrarenal nitric oxide formation, that could alter the ability of the kidney to excrete a salt load.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205240     DOI: 10.1161/01.hyp.33.4.1013

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  42 in total

1.  Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury.

Authors:  Bing Li; Amy Cohen; Thomas E Hudson; Delara Motlagh; David L Amrani; Jeremy S Duffield
Journal:  Circulation       Date:  2010-05-10       Impact factor: 29.690

Review 2.  Renal oxidative stress, oxygenation, and hypertension.

Authors:  Fredrik Palm; Lina Nordquist
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

Review 3.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

4.  An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.

Authors:  John D Imig; Xueying Zhao; Constantine Z Zaharis; Jeffrey J Olearczyk; David M Pollock; John W Newman; In-Hae Kim; Takaho Watanabe; Bruce D Hammock
Journal:  Hypertension       Date:  2005-09-12       Impact factor: 10.190

Review 5.  Does dietary salt increase the risk for progression of kidney disease?

Authors:  Shiraz I Mishra; Charlotte Jones-Burton; Jeffrey C Fink; Jeanine Brown; George L Bakris; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 6.  Pathogenesis of essential hypertension: historical paradigms and modern insights.

Authors:  Richard J Johnson; Dan I Feig; Takahiko Nakagawa; L Gabriela Sanchez-Lozada; Bernardo Rodriguez-Iturbe
Journal:  J Hypertens       Date:  2008-03       Impact factor: 4.844

7.  Salt Sensitivity in Response to Renal Injury Requires Renal Angiotensin-Converting Enzyme.

Authors:  Jorge F Giani; Kenneth E Bernstein; Tea Janjulia; Jiyang Han; Jorge E Toblli; Xiao Z Shen; Bernardo Rodriguez-Iturbe; Alicia A McDonough; Romer A Gonzalez-Villalobos
Journal:  Hypertension       Date:  2015-07-06       Impact factor: 10.190

Review 8.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 9.  Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies.

Authors:  John W Wright; Shigehiko Mizutani; Joseph W Harding
Journal:  Heart Fail Rev       Date:  2007-11-07       Impact factor: 4.214

Review 10.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.